Epidemiologic and molecular prognostic review of glioblastoma

JP Thakkar, TA Dolecek, C Horbinski, QT Ostrom… - … , biomarkers & prevention, 2014 - AACR
Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous
system malignancy with a median survival of 15 months. The average incidence rate of GBM …
被引用次数：1756 相关文章

Epidemiologic and molecular prognostic review of glioblastoma

JP Thakkar, TA Dolecek… - Cancer …, 2014 - scholars.northwestern.edu
Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous
system malignancy with a median survival of 15 months. The average incidence rate of GBM …
[HTML] nih.gov

[HTML][HTML] Epidemiologic and Molecular Prognostic Review of Glioblastoma

JP Thakkar, TA Dolecek, C Horbinski… - … & prevention: a …, 2014 - ncbi.nlm.nih.gov
Glioblastoma (GBM) is the most common and aggressive primary CNS malignancy with a
median survival of 15 months. The average incidence rate (IR) of GBM is 3.19/100,000 …

Epidemiologic and molecular prognostic review of glioblastoma.

JP Thakkar, TA Dolecek, C Horbinski… - … & Prevention: a …, 2014 - europepmc.org
Glioblastoma (GBM) is the most common and aggressive primary CNS malignancy with a
median survival of 15 months. The average incidence rate (IR) of GBM is 3.19/100,000 …
[PDF] psu.edu

[PDF][PDF] Epidemiologic and Molecular Prognostic Review of Glioblastoma

JP Thakkar, TA Dolecek, C Horbinski, QT Ostrom… - Citeseer
Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous
system malignancy with a median survival of 15 months. The average incidence rate of GBM …

Epidemiologic and Molecular Prognostic Review of Glioblastoma

JP Thakkar, TA Dolecek, C Horbinski… - Cancer Epidemiology …, 2014 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Glioblastoma multiforme (GBM) is the most
common and aggressive primary central nervous system malignancy with a median survival …

Epidemiologic and molecular prognostic review of glioblastoma

JP Thakkar, TA Dolecek, C Horbinski… - … & prevention: a …, 2014 - pubmed.ncbi.nlm.nih.gov
Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous
system malignancy with a median survival of 15 months. The average incidence rate of GBM …

Epidemiologic and Molecular Prognostic Review of Glioblastoma

JP Thakkar, TA Dolecek, C Horbinski, QT Ostrom… - 2014 - stacks.cdc.gov
Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous
system malignancy with a median survival of 15 months. The average incidence rate of GBM …
[PDF] researchgate.net

[PDF][PDF] Epidemiologic and Molecular Prognostic Review of Glioblastoma

JP Thakkar, TA Dolecek, C Horbinski - researchgate.net
Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous
system malignancy with a median survival of 15 months. The average incidence rate of GBM …

Epidemiologic and molecular prognostic review of glioblastoma.

JP Thakkar, TA Dolecek, C Horbinski, QT Ostrom… - 2014 - cabidigitallibrary.org
Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous
system malignancy with a median survival of 15 months. The average incidence rate of GBM …